Related Experiment Video
Updated: Oct 8, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Influence of novel and conventional antipsychotic medication on subjective quality of life
1McGill University Health Centre, Montreal General Hospital, 1650 Cedar Ave., Montreal QC H3G 1A4. raymond.tempier@muhc.mcgill.ca
Objective:
To assess the impact of novel antipsychotic medication on the subjective quality of life of patients with schizophrenia and schizoaffective disorders.
Design:
Retrospective, cross-sectional analysis of data from 2 studies conducted in 1997 and 1998.
Patients:
91 outpatients (50 men and 41 women, mean age 43.3 years) diagnosed with schizophrenia (n = 70) and schizoaffective disorder (n = 21); the mean Global Assessment of Functioning score for these patients was 48.0 (standard deviation 12.5).
Outcome Measure:
Patients were categorized into 1 of 3 groups: those taking conventional (n = 41), novel (n = 26) or mixed (both conventional and novel) (n = 24) antipsychotics. Responses on the Satisfaction with Life Domains Scale were used to assess subjective quality of life.
Results:
The type of antipsychotic medication taken did not influence satisfaction with life scores; in fact, 2 items dealing with social relationships were scored lower by those taking novel antipsychotics.
Conclusions:
Patients taking novel antipsychotics may expect more from life, and this might explain their lower quality-of-life scores.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: MAOIs and Other Agents